|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: FRA10AC1 |
Gene summary for FRA10AC1 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | FRA10AC1 | Gene ID | 118924 |
| Gene name | FRA10A associated CGG repeat 1 | |
| Gene Alias | C10orf4 | |
| Cytomap | 10q23.33 | |
| Gene Type | protein-coding | GO ID | GO:0006793 | UniProtAcc | Q70Z53 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 118924 | FRA10AC1 | LZE4T | Human | Esophagus | ESCC | 4.95e-14 | 2.71e-01 | 0.0811 |
| 118924 | FRA10AC1 | LZE5T | Human | Esophagus | ESCC | 3.68e-03 | 1.42e-01 | 0.0514 |
| 118924 | FRA10AC1 | LZE7T | Human | Esophagus | ESCC | 1.93e-04 | 2.74e-01 | 0.0667 |
| 118924 | FRA10AC1 | LZE8T | Human | Esophagus | ESCC | 2.27e-04 | 1.13e-01 | 0.067 |
| 118924 | FRA10AC1 | LZE22D1 | Human | Esophagus | HGIN | 3.89e-02 | 1.28e-01 | 0.0595 |
| 118924 | FRA10AC1 | LZE24T | Human | Esophagus | ESCC | 2.15e-14 | 3.41e-01 | 0.0596 |
| 118924 | FRA10AC1 | LZE21T | Human | Esophagus | ESCC | 2.41e-02 | 2.99e-01 | 0.0655 |
| 118924 | FRA10AC1 | P1T-E | Human | Esophagus | ESCC | 2.68e-02 | 9.41e-02 | 0.0875 |
| 118924 | FRA10AC1 | P2T-E | Human | Esophagus | ESCC | 1.29e-32 | 5.23e-01 | 0.1177 |
| 118924 | FRA10AC1 | P4T-E | Human | Esophagus | ESCC | 2.08e-25 | 5.10e-01 | 0.1323 |
| 118924 | FRA10AC1 | P5T-E | Human | Esophagus | ESCC | 6.52e-18 | 2.64e-01 | 0.1327 |
| 118924 | FRA10AC1 | P8T-E | Human | Esophagus | ESCC | 1.75e-18 | 2.50e-01 | 0.0889 |
| 118924 | FRA10AC1 | P9T-E | Human | Esophagus | ESCC | 3.54e-13 | 2.05e-01 | 0.1131 |
| 118924 | FRA10AC1 | P10T-E | Human | Esophagus | ESCC | 4.70e-18 | 2.55e-01 | 0.116 |
| 118924 | FRA10AC1 | P11T-E | Human | Esophagus | ESCC | 1.13e-12 | 4.17e-01 | 0.1426 |
| 118924 | FRA10AC1 | P12T-E | Human | Esophagus | ESCC | 6.07e-32 | 5.92e-01 | 0.1122 |
| 118924 | FRA10AC1 | P15T-E | Human | Esophagus | ESCC | 2.59e-26 | 5.03e-01 | 0.1149 |
| 118924 | FRA10AC1 | P16T-E | Human | Esophagus | ESCC | 3.54e-28 | 4.30e-01 | 0.1153 |
| 118924 | FRA10AC1 | P17T-E | Human | Esophagus | ESCC | 3.05e-08 | 2.92e-01 | 0.1278 |
| 118924 | FRA10AC1 | P20T-E | Human | Esophagus | ESCC | 1.42e-30 | 6.13e-01 | 0.1124 |
| Page: 1 2 3 4 5 6 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:001631110 | Esophagus | ESCC | dephosphorylation | 251/8552 | 417/18723 | 1.26e-09 | 2.99e-08 | 251 |
| GO:001631111 | Liver | Cirrhotic | dephosphorylation | 130/4634 | 417/18723 | 1.58e-03 | 1.03e-02 | 130 |
| GO:001631121 | Liver | HCC | dephosphorylation | 230/7958 | 417/18723 | 1.00e-07 | 1.96e-06 | 230 |
| GO:00163119 | Oral cavity | OSCC | dephosphorylation | 220/7305 | 417/18723 | 6.33e-09 | 1.34e-07 | 220 |
| GO:001631116 | Thyroid | PTC | dephosphorylation | 174/5968 | 417/18723 | 1.20e-05 | 1.31e-04 | 174 |
| GO:001631117 | Thyroid | ATC | dephosphorylation | 179/6293 | 417/18723 | 3.88e-05 | 3.15e-04 | 179 |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| FRA10AC1 | SNV | Missense_Mutation | c.43N>C | p.Glu15Gln | p.E15Q | Q70Z53 | protein_coding | deleterious(0.03) | benign(0.255) | TCGA-A8-A0A9-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | anastrozole | SD | |
| FRA10AC1 | SNV | Missense_Mutation | c.387N>T | p.Lys129Asn | p.K129N | Q70Z53 | protein_coding | deleterious(0.01) | probably_damaging(0.96) | TCGA-EK-A2R8-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
| FRA10AC1 | SNV | Missense_Mutation | c.160G>C | p.Glu54Gln | p.E54Q | Q70Z53 | protein_coding | tolerated(0.17) | benign(0.043) | TCGA-EK-A3GK-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
| FRA10AC1 | SNV | Missense_Mutation | c.580N>A | p.Gly194Ser | p.G194S | Q70Z53 | protein_coding | tolerated(0.09) | possibly_damaging(0.78) | TCGA-A6-5659-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
| FRA10AC1 | SNV | Missense_Mutation | c.611N>T | p.Ala204Val | p.A204V | Q70Z53 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-AA-3815-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
| FRA10AC1 | SNV | Missense_Mutation | c.399N>T | p.Lys133Asn | p.K133N | Q70Z53 | protein_coding | deleterious(0) | possibly_damaging(0.824) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
| FRA10AC1 | SNV | Missense_Mutation | novel | c.346N>A | p.Leu116Ile | p.L116I | Q70Z53 | protein_coding | tolerated(0.05) | probably_damaging(0.974) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
| FRA10AC1 | insertion | Frame_Shift_Ins | novel | c.694_695insA | p.Arg232LysfsTer4 | p.R232Kfs*4 | Q70Z53 | protein_coding | TCGA-AA-3713-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | 5-fluorouracil | PR | ||
| FRA10AC1 | deletion | Frame_Shift_Del | rs775948504 | c.694delN | p.Arg232GlufsTer96 | p.R232Efs*96 | Q70Z53 | protein_coding | TCGA-CM-6162-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | oxaliplatin | SD | ||
| FRA10AC1 | deletion | Frame_Shift_Del | rs750462341 | c.621delA | p.Lys207AsnfsTer2 | p.K207Nfs*2 | Q70Z53 | protein_coding | TCGA-EI-6507-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
| Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |